Related Experiment Video
Updated: Mar 15, 2026

09:54
Synthesis and Characterization of 1,2-Dithiolane Modified Self-Assembling Peptides
Published on: August 20, 2018
7.8K
Conformational Restriction of Peptides Using Dithiol Bis-Alkylation
L Peraro1, T R Siegert1, J A Kritzer1
1Tufts University, Medford, MA, United States.
Methods in Enzymology
|September 3, 2016
Summary
Macrocyclic peptides offer promise for inhibiting protein-protein interactions. Dithiol bis-alkylation reactions provide a versatile method for creating these conformationally constrained cyclic peptides efficiently.
Area of Science:
- Medicinal Chemistry
- Organic Chemistry
- Biochemistry
Background:
- Macrocyclic peptides are valuable as inhibitors of protein-protein interactions.
- Traditional cyclic peptide synthesis methods face limitations in accessing diverse chemical space.
- Cysteine alkylation reactions have emerged as a versatile approach for cyclic peptide discovery.
Purpose of the Study:
- To detail applications, methods, and mechanistic insights of dithiol bis-alkylation reactions for cyclic peptide production.
- To provide troubleshooting guidance for this macrocyclization technique.
- To highlight the utility of this method for generating loop-based protein-protein interaction inhibitors.
Main Methods:
- Utilizing dithiol bis-alkylation reactions for macrocyclization.
- Employing solution-phase synthesis for efficient cyclic peptide production.
- Applying rational design and library approaches for cyclic peptide discovery.
Main Results:
- Demonstrated versatility and robustness of cysteine alkylation chemistry for cyclic peptide synthesis.
- Enabled production of a wide array of conformationally constrained cyclic peptides.
- Facilitated rapid production and screening of loop-based inhibitors.
Conclusions:
- Dithiol bis-alkylation is an efficient solution-phase macrocyclization strategy.
- This method is highly effective for the rapid discovery and development of cyclic peptide inhibitors.
- The described chemistry expands access to conformationally constrained cyclic peptides for therapeutic applications.

